Citation

Cotrim Bruno A., Barros José C. (2022) Development and patent synthesis of nirmatrelvir – the main component of the first oral drug against SARS-CoV-2 Paxlovid®. Australian Journal of Chemistry 75, 487-491.

https://doi.org/10.1071/CH22104